Bristol-Myers Squibb Co
XETRA:BRM
Bristol-Myers Squibb Co
XETRA:BRM
Price:
52.3
EUR
0.5%
Market Closed
Market Cap:
€106B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
Banco Comercial Portugues SA
ELI:BCP
|
PT |
|
Nordic Entertainment Group AB
OTC:NENTF
|
SE |
|
China Merchants Property Operation & Service Co Ltd
SZSE:001914
|
CN |
|
B
|
Bonny International Holding Ltd
HKEX:1906
|
CN |
|
N
|
Nordic Semiconductor ASA
XBER:N0S
|
NO |
|
T
|
Transwarp Technology Shanghai Co Ltd
SSE:688031
|
CN |
|
Century 21 Real Estate of Japan Ltd
TSE:8898
|
JP |
Multiples-Based Value
The Multiples-Based Value of one
BRM
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 52.3 EUR,
Bristol-Myers Squibb Co
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BRM Multiples-Based Value
LOCKED
Multiples Across Competitors
BRM Competitors Multiples
Bristol-Myers Squibb Co Competitors
Bristol-Myers Squibb Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
XETRA:BRM
|
122.1B EUR | 2.5 | 17.3 | 7.3 | 9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
99.8B EUR | 2.1 | 12.8 | 10.7 | 10.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
